Shinde, Sagar, et al. “Overview on Remogliflozin SGLT-2 Inhibitor in the Management of Type-2 Diabetic Mellitus in Human Beings”. Fundamental and Experimental Biology, vol. 112, no. 4, Dec. 2023, pp. 156-67, doi:10.31489/2023bmg4/156-167.